. 2020 Jul 23;11:1101. doi: 10.3389/fphar.2020.01101

Table 5.

Base case analysis and one-way sensitivity analysis on time horizon and initial New York Heart Association (NYHA) class distribution.

	Treatment strategies	Cost($)	Incremental cost ($)	QALY	Incremental QALYs	ICER($/QALYs)
Base case	Sac-val	4,684.25	669.78	4.67	0.27	2,480.67
Base case	Enalapril	4,014.47	669.78	4.40	0.27	2,480.67
Time horizon
5-years	Sac-val	2,973.81	362.99	2.95	0.10	3,684.57
5-years	Enalapril	2,610.82	362.99	2.85	0.10	3,684.57
15-years	Sac-val	5,661.36	900.47	5.64	0.44	2,032.52
15-years	Enalapril	4,760.89	900.47	5.20	0.44	2,032.52
20-years	Sac-val	6,170.73	1,049.23	6.14	0.56	1,874.00
20-years	Enalapril	5,121.5	1,049.23	5.58	0.56	1,874.00
Initial NYHA class distribution:5% I; 20% II; 45% III; 30% IV
5-years	Sac-val	2,995.24	379.67	2.73	0.09	4,175.26
5-years	Enalapril	2,615.57	379.67	2.64	0.09	4,175.26
10-years	Sac-val	4,609.59	687.66	4.33	0.25	2,697.82
10-years	Enalapril	3,921.93	687.66	4.08	0.25	2,697.82
20-years	Sac-val	5,977.42	1,044.35	5.69	0.51	2,030.94
20-years	Enalapril	4,933.07	1,044.35	5.17	0.51	2,030.94